Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

An atlas of bloodstream-accessible bone marrow proteins for site-directed therapy of acute myeloid leukemia.

Angenendt L, Reuter S, Kentrup D, Benk AS, Neumann F, Hüve J, Martens AC, Schwöppe C, Kessler T, Schmidt LH, Sauer T, Brand C, Mikesch JH, Lenz G, Mesters RM, Müller-Tidow C, Hartmann W, Wardelmann E, Neri D, Berdel WE, Roesli C, Schliemann C.

Leukemia. 2018 Feb;32(2):510-519. doi: 10.1038/leu.2017.208. Epub 2017 Jun 30.

PMID:
28663580
2.

Identification and Validation of Novel Subtype-Specific Protein Biomarkers in Pancreatic Ductal Adenocarcinoma.

Kuhlmann L, Nadler WM, Kerner A, Hanke SA, Noll EM, Eisen C, Espinet E, Vogel V, Trumpp A, Sprick MR, Roesli CP.

Pancreas. 2017 Mar;46(3):311-322. doi: 10.1097/MPA.0000000000000743.

PMID:
27846146
3.

MALDI-TOF and nESI Orbitrap MS/MS identify orthogonal parts of the phosphoproteome.

Ruprecht B, Roesli C, Lemeer S, Kuster B.

Proteomics. 2016 May;16(10):1447-56. doi: 10.1002/pmic.201500523. Epub 2016 May 2.

PMID:
26990019
4.

Ion source-dependent performance of 4-vinylpyridine, iodoacetamide, and N-maleoyl derivatives for the detection of cysteine-containing peptides in complex proteomics.

Nadler W, Berg R, Walch P, Hanke S, Baalmann M, Kerner A, Trumpp A, Roesli C.

Anal Bioanal Chem. 2016 Mar;408(8):2055-67. doi: 10.1007/s00216-015-9113-4. Epub 2015 Oct 22.

PMID:
26493978
5.

Recent advances in proteomically subtyping pancreatic ductal adenocarcinomas and their potential clinical impact.

Roesli C.

Expert Rev Proteomics. 2015 Feb;12(1):5-8. doi: 10.1586/14789450.2015.983478. Epub 2014 Nov 19.

PMID:
25407217
6.

A comprehensive surface proteome analysis of myeloid leukemia cell lines for therapeutic antibody development.

Strassberger V, Gutbrodt KL, Krall N, Roesli C, Takizawa H, Manz MG, Fugmann T, Neri D.

J Proteomics. 2014 Mar 17;99:138-51. doi: 10.1016/j.jprot.2014.01.022. Epub 2014 Jan 30.

PMID:
24487095
7.

Label-free quantification using MALDI mass spectrometry: considerations and perspectives.

Benk AS, Roesli C.

Anal Bioanal Chem. 2012 Sep;404(4):1039-56. doi: 10.1007/s00216-012-5832-y. Epub 2012 Feb 23. Review.

PMID:
22358999
8.

Proteomic identification of vanin-1 as a marker of kidney damage in a rat model of type 1 diabetic nephropathy.

Fugmann T, Borgia B, Révész C, Godó M, Forsblom C, Hamar P, Holthöfer H, Neri D, Roesli C.

Kidney Int. 2011 Aug;80(3):272-81. doi: 10.1038/ki.2011.116. Epub 2011 May 4.

9.

The accessible cerebral vascular proteome in a mouse model of cerebral β-amyloidosis.

Roesli C, Fugmann T, Borgia B, Schliemann C, Neri D, Jucker M.

J Proteomics. 2011 Apr 1;74(4):539-46. doi: 10.1016/j.jprot.2011.01.010. Epub 2011 Jan 22.

PMID:
21262399
10.

A novel reactive ester derivative of biotin with reduced membrane permeability for in vivo biotinylation experiments.

Strassberger V, Trüssel S, Fugmann T, Neri D, Roesli C.

Proteomics. 2010 Oct;10(19):3544-8. doi: 10.1002/pmic.201000308.

PMID:
20821733
11.

Expression, engineering and characterization of the tumor-targeting heterodimeric immunocytokine F8-IL12.

Sommavilla R, Pasche N, Trachsel E, Giovannoni L, Roesli C, Villa A, Neri D, Kaspar M.

Protein Eng Des Sel. 2010 Aug;23(8):653-61. doi: 10.1093/protein/gzq038. Epub 2010 Jun 15.

PMID:
20551083
12.

Methods for the identification of vascular markers in health and disease: from the bench to the clinic.

Roesli C, Neri D.

J Proteomics. 2010 Oct 10;73(11):2219-29. doi: 10.1016/j.jprot.2010.05.017. Epub 2010 Jun 10. Review.

PMID:
20541635
13.

Chemical proteomic and bioinformatic strategies for the identification and quantification of vascular antigens in cancer.

Strassberger V, Fugmann T, Neri D, Roesli C.

J Proteomics. 2010 Sep 10;73(10):1954-73. doi: 10.1016/j.jprot.2010.05.018. Epub 2010 Jun 9.

PMID:
20538087
14.

DeepQuanTR: MALDI-MS-based label-free quantification of proteins in complex biological samples.

Fugmann T, Neri D, Roesli C.

Proteomics. 2010 Jul;10(14):2631-43. doi: 10.1002/pmic.200900634.

PMID:
20455210
15.

Tumour-targeting properties of antibodies specific to MMP-1A, MMP-2 and MMP-3.

Pfaffen S, Frey K, Stutz I, Roesli C, Neri D.

Eur J Nucl Med Mol Imaging. 2010 Aug;37(8):1559-65. doi: 10.1007/s00259-010-1446-9. Epub 2010 Apr 20.

PMID:
20405286
16.

A proteomic approach for the identification of vascular markers of liver metastasis.

Borgia B, Roesli C, Fugmann T, Schliemann C, Cesca M, Neri D, Giavazzi R.

Cancer Res. 2010 Jan 1;70(1):309-18. doi: 10.1158/0008-5472.CAN-09-2939. Epub 2009 Dec 8.

17.

In vivo biotinylation of the vasculature in B-cell lymphoma identifies BST-2 as a target for antibody-based therapy.

Schliemann C, Roesli C, Kamada H, Borgia B, Fugmann T, Klapper W, Neri D.

Blood. 2010 Jan 21;115(3):736-44. doi: 10.1182/blood-2009-08-239004. Epub 2009 Nov 10.

18.

Comparative analysis of the membrane proteome of closely related metastatic and nonmetastatic tumor cells.

Roesli C, Borgia B, Schliemann C, Gunthert M, Wunderli-Allenspach H, Giavazzi R, Neri D.

Cancer Res. 2009 Jul 1;69(13):5406-14. doi: 10.1158/0008-5472.CAN-08-0999. Epub 2009 Jun 2.

19.

Improved protein sequence coverage by on resin deglycosylation and cysteine modification for biomarker discovery.

Kamada H, Fugmann T, Neri D, Roesli C.

Proteomics. 2009 Feb;9(3):783-7. doi: 10.1002/pmic.200800466.

PMID:
19137555
20.

Identification of new accessible tumor antigens in human colon cancer by ex vivo protein biotinylation and comparative mass spectrometry analysis.

Conrotto P, Roesli C, Rybak J, Kischel P, Waltregny D, Neri D, Castronovo V.

Int J Cancer. 2008 Dec 15;123(12):2856-64. doi: 10.1002/ijc.23861.

21.

Identification of the surface-accessible, lineage-specific vascular proteome by two-dimensional peptide mapping.

Roesli C, Mumprecht V, Neri D, Detmar M.

FASEB J. 2008 Jun;22(6):1933-44. doi: 10.1096/fj.07-100529. Epub 2008 Jan 7.

PMID:
18180333
22.

A monoclonal antibody prevents aggregation of the NBD1 domain of the cystic fibrosis transmembrane conductance regulator.

Lovato V, Roesli C, Ahlskog J, Scheuermann J, Neri D.

Protein Eng Des Sel. 2007 Dec;20(12):607-14. Epub 2007 Nov 30.

PMID:
18055505
23.

The extra-domain A of fibronectin is a vascular marker of solid tumors and metastases.

Rybak JN, Roesli C, Kaspar M, Villa A, Neri D.

Cancer Res. 2007 Nov 15;67(22):10948-57.

25.

A chemical proteomics approach for the identification of accessible antigens expressed in human kidney cancer.

Castronovo V, Waltregny D, Kischel P, Roesli C, Elia G, Rybak JN, Neri D.

Mol Cell Proteomics. 2006 Nov;5(11):2083-91. Epub 2006 Jul 21.

26.

Two-dimensional mass spectrometric mapping.

Roesli C, Elia G, Neri D.

Curr Opin Chem Biol. 2006 Feb;10(1):35-41. Epub 2006 Jan 6. Review.

PMID:
16406768
28.

Identification and relative quantification of membrane proteins by surface biotinylation and two-dimensional peptide mapping.

Scheurer SB, Rybak JN, Roesli C, Brunisholz RA, Potthast F, Schlapbach R, Neri D, Elia G.

Proteomics. 2005 Jul;5(11):2718-28.

PMID:
15986331

Supplemental Content

Loading ...
Support Center